Epoprostenol - NDC Database
6 records found
Page:
0703-1985 Apr 23, 2008
Epoprostenol Sodium .5 mg/1 Intravenous Injection, Powder, for Solution by Teva Parenteral Medicines, Inc.
Epoprostenol Sodium .5 mg/1 Intravenous Injection, Powder, for Solution by Teva Parenteral Medicines, Inc.
0703-1995 Apr 23, 2008
Epoprostenol Sodium 1.5 mg/1 Intravenous Injection, Powder, for Solution by Teva Parenteral Medicines, Inc.
Epoprostenol Sodium 1.5 mg/1 Intravenous Injection, Powder, for Solution by Teva Parenteral Medicines, Inc.
62756-059 Jan 16, 2021
Epoprostenol .5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Sun Pharmaceutical Industries Limited
Epoprostenol .5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Sun Pharmaceutical Industries Limited
62756-060 Jan 16, 2021
Epoprostenol 1.5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Sun Pharmaceutical Industries Limited
Epoprostenol 1.5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Sun Pharmaceutical Industries Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.